Pinion Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,342
| Closed | -$290K | – | 217 |
|
|
2026
Q1 | $290K | Sell |
10,342
-2,133
| -17% | -$56.8K | 0.07% | 150 |
|
|
2025
Q4 | $311K | Sell |
12,475
-126
| -1% | -$3.18K | 0.08% | 136 |
|
|
2025
Q3 | $312K | Buy |
+12,601
| New | +$311K | 0.09% | 134 |
|
|
2024
Q1 | – | Sell |
-7,966
| Closed | -$229K | – | 159 |
|
|
2023
Q4 | $229K | Buy |
7,966
+35
| +0.4% | +$1.06K | 0.14% | 137 |
|
|
2023
Q3 | $263K | Sell |
7,931
-9,539
| -55% | -$337K | 0.17% | 134 |
|
|
2023
Q2 | $641K | Buy |
17,470
+1,928
| +12% | +$75K | 0.43% | 48 |
|
|
2023
Q1 | $634K | Buy |
15,542
+1,178
| +8% | +$50.9K | 0.59% | 41 |
|
|
2022
Q4 | $736K | Sell |
14,364
-1,963
| -12% | -$94.1K | 0.69% | 37 |
|
|
2022
Q3 | $714K | Buy |
16,327
+842
| +5% | +$40.9K | 0.62% | 36 |
|
|
2022
Q2 | $812K | Buy |
15,485
+4,427
| +40% | +$226K | 0.68% | 40 |
|
|
2022
Q1 | $572K | Sell |
11,058
-34
| -0.3% | -$1.76K | 0.4% | 79 |
|
|
2021
Q4 | $655K | Sell |
11,092
-53
| -0.5% | -$2.63K | 0.44% | 72 |
|
|
2021
Q3 | $479K | Buy |
11,145
+90
| +0.8% | +$3.99K | 0.39% | 83 |
|
|
2021
Q2 | $433K | Sell |
11,055
-51
| -0.5% | -$1.98K | 0.35% | 100 |
|
|
2021
Q1 | $402K | Buy |
11,106
+414
| +4% | +$14.7K | 0.37% | 99 |
|
|
2020
Q4 | $394K | Buy |
10,692
+95
| +0.9% | +$3.48K | 0.41% | 80 |
|
|
2020
Q3 | $329K | Hold |
10,597
| – | – | 0.5% | 79 |
|
|
2020
Q2 | $329K | Sell |
10,597
-1,340
| -11% | -$45.5K | 0.5% | 79 |
|
|
2020
Q1 | $370K | Buy |
11,937
+1,129
| +10% | +$38.5K | 0.79% | 63 |
|
|
2019
Q4 | $402K | Buy |
10,808
+1,138
| +12% | +$40.5K | 0.75% | 63 |
|
|
2019
Q3 | $330K | Buy |
9,670
+190
| +2% | +$6.91K | 0.68% | 79 |
|
|
2019
Q2 | $390K | Sell |
9,480
-751
| -7% | -$29.8K | 0.84% | 59 |
|
|
2019
Q1 | $412K | Buy |
10,231
+474
| +5% | +$19K | 0.72% | 64 |
|
|
2018
Q4 | $404K | Buy |
9,757
+497
| +5% | +$20.6K | 0.85% | 54 |
|
|
2018
Q3 | $387K | Sell |
9,260
-653
| -7% | -$25.1K | 0.74% | 61 |
|
|
2018
Q2 | $341K | Buy |
9,913
+26
| +0.3% | +$889 | 0.66% | 70 |
|
|
2018
Q1 | $333K | Buy |
+9,887
| New | +$340K | 0.71% | 66 |
|
Other funds holding PFE
Pinion Investment Advisors's PFE Position: Q2 2026 in Review
Pinion Investment Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 10,342 shares — an estimated $290K sold.
Pinion Investment Advisors first reported a position in PFE in Q1 2018 and held it in 27 quarters. The position peaked at $812K in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pinion Investment Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Pinion Investment Advisors sold 10,342 Pfizer shares in Q2 2026, an estimated $290K.
- Pinion Investment Advisors first reported a position in Pfizer in Q1 2018 and held it in 27 quarters.
- Pinion Investment Advisors's Pfizer position peaked at $812K in Q2 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pinion Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.